News: Front Section

D’Aveta of Cummings Properties assists Spectrus in 2,400 s/f lease

Beverly, MA Spectrus has graduated from an incubator lab to 2,400 s/f of space at Cummings Center’s growing biotech cluster. The mass spectrometry firm is expected to occupy its new facilities this summer. Founded in 2017 by Enrique Arevalo and Michael Ziebell, Spectrus provides proteomics services and advanced analytics for biotech and pharmaceutical development organizations.

The life sciences firm is the latest graduate of North Shore InnoVentures, a nonprofit biotech and cleantech incubator located at Cummings Center. The growth of its business from just one to 40 active accounts in the span of a few years prompted the firm to explore independent space options.

“Cummings Center is a great fit for us because it is a short distance from our primary customer base in Cambridge and Boston, its active life science community facilitates connections and hiring, and the lease rates are more affordable than areas closer to the city,” said Ziebell.

Cummings Properties account manager Justin D’Aveta worked with Spectrus CEO Paulo Reátegui on the new office lease. With discussions taking place during the height of Massachusetts’ COVID-19 outbreak, D’Aveta arranged a virtual tour of the suite for the Spectrus team. 

“At Cummings Center, we have a front-row seat to the continued development of the North Shore’s thriving biotech community,” said Stephanie Aitchison, associate general manager at Cummings Center. “We are delighted to support Spectrus’ continued growth.”

According to Ziebell, Spectrus aims to steadily increase its full-time workforce each year.

“We are really excited about the room for growth this space affords, said Ziebell. “We think Spectrus has the right balance of scientific knowledge and business sense to grow rapidly in the years ahead, and we look forward to making Cummings our base for this growth and giving back to the community as we do so.”

Spectrus remained operational throughout the recent business closures across the Commonwealth and participated in COVID-19 relief efforts with research in virus detection methods.

MORE FROM Front Section
Front Section

McEvoy of The Conrad Group brokers $2.9 million sale of industrial building

Hingham, MA The Conrad Group  has brokered the sale of 55 Research Rd., South Shore Park. The property consists of a 20,340 s/f single story manufacturing building on two acres of land.
READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
The doctor is in: How medical leases differ from retail and office spaces - by Brian Cafferty

The doctor is in: How medical leases differ from retail and office spaces - by Brian Cafferty

As healthcare facilities, often referred to as “Doc in a Box” clinics, increasingly move into traditional retail spaces, landlords are more frequently leasing to medical tenants. Unlike standard retail or office leases, medical facilities come with a unique set of considerations that must be carefully addressed to ensure a successful tenancy.
It’s time to get creative with closed college campuses - by Christian Koulichkov

It’s time to get creative with closed college campuses - by Christian Koulichkov

Facing higher costs, shrinking enrollments, reduced state funding and severe demographic headwinds, many colleges and universities in New England and the Northeast are fighting for survival. The latest to lose the battle is the 150 + year old University of the Arts in
Newmark negotiates sale of  10 Liberty Sq. and 12 Post Office Sq.

Newmark negotiates sale of 10 Liberty Sq. and 12 Post Office Sq.

Boston, MA Newmark has completed the sale of 10 Liberty Sq. and 12 Post Office Sq. Newmark co-head of U.S. Capital Markets Robert Griffin and Boston Capital Markets executive vice chairman Edward Maher, vice chairman Matthew Pullen, executive managing director James Tribble,
Investing in a falling rate environment - by Harrison Klein

Investing in a falling rate environment - by Harrison Klein

Long-term interest rates have fallen by 100 basis points, and the market is normalizing. In December of 2022 I wrote an article about investing in a high interest rate, high inflation market. Since then, inflation has cooled off, and the Fed has begun lowering their funds rate.